Search company, investor...

Exotic Technologies

Stage

Incubator/Accelerator | Alive

About Exotic Technologies

After two years of development, testing and continuous improvement and trials at various hospitals, INFLO Infusion Flow Rate Monitor was introduced. INFLO is a microprocessor-controlled device with high level of accuracy, which can be used to monitor the infusion flow rate. Its low cost and low operating expenses as well as long life cycle aims to make it an alternative to the expensive infusion monitoring devices and aims to give accuracy and safety with inexpensive infusion sets.

Headquarters Location

India

Missing: Exotic Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Exotic Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Exotic Technologies Frequently Asked Questions (FAQ)

  • What is Exotic Technologies's latest funding round?

    Exotic Technologies's latest funding round is Incubator/Accelerator.

  • Who are the investors of Exotic Technologies?

    Investors of Exotic Technologies include Centre for Innovation Incubation and Entrepreneurship.

  • Who are Exotic Technologies's competitors?

    Competitors of Exotic Technologies include Senseonics, OptiScan Biomedical, Cardiopulmonary, Corpora Systems, eCardio Diagnostics and 13 more.

Compare Exotic Technologies to Competitors

G
Glucose Sensing Technologies

Vytrace Corporation (fka Glucose Sensing Technologies) is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

V
Vytrace

Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

I
IntelliDx

IntelliDx, Inc. is a development stage medical device company focused on the commercialization of an automated blood glucose monitoring device.

V
VivoMetrics

VivoMetrics provides continuous ambulatory monitoring products and services for the collection, analysis, and reporting of patient specific physiologic data serving pharmaceutical, biotechnology, and device companies.

L
Luminous Medical

Luminous Medical is developing a new device to allow the near continuous measurement of blood glucose and other analytes in the hospital environment.

I
InformMed

InformMed is a medication safety company developing, patenting and commercializing product and service-based solutions for the growing medication error solution market. InformMed is focused on providing nurses and pharmacists with performance support tools that aid in the level of safety for patients, caregivers and healthcare providers. InformMed's patented flagship product, pac2, is a hand-held performance-support system designed to help nurses prevent wrong dose errors at the point of care, a major healthcare concern.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.